4.16
4.16 (0%)
As of Feb 14, 2025
Protara Therapeutics, Inc. [TARA]
Source:
Company Overview
Protara Therapeutics, Inc is a New York City based clinical-stage biopharmaceutical company committed to advancing transformative therapies for the treatment of cancer and rare diseases.
| Country | United States |
| Headquarters | new york, new york |
| Phone Number | 646-844-0337 |
| Industry | manufacturing |
| CEO | Jesse Shefferman |
| Website | www.protaratx.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | |
| Operating Profit | $-49.2 |
| Net Income | $-44.6 |
| Net Cash | $123.2 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -34.3% |
| Profit as % of Stockholder Equity | -26.7% |
Management Effectiveness
| Return on Equity | -26.7% |
| Return on Assets | -24.6% |
| Turnover Ratio | |
| EBITA | $-49.2 |
Balance Sheet and Cash Flow Measures
| Total Assets | $181.5 |
| Total Liabilities | $14.3 |
| Operating Cash Flow | $-35.8 |
| Investing Cash Flow | $19.2 |
| Financing Cash Flow | $139.9 |
